ChinaBio® Today Articles

Welcome to the ChinaBio® Today store. As a service to our readers, we offer access to individual articles for only $5.00 (USD) each.  Of course, a subscription is only $20/mo, so you may prefer to subscribe.  If so, click on Subscribe in the menu.

Browse


All Products

Viewing 5176 - 5190 of 5996 products
3SBio
$5.00
Available
WHO Declares China's H7N9 Flu Crisis Over; Cost was $6.5 Billion
$5.00
Available
Zensun Announces Positive Data from Phase II Trials of Neucardin
$5.00
Available
CFDA Approves Clinical Trials for Novel China AIDS Treatment
$5.00
Available
China's Curative Medical to Seek CFDA Approval for ALung's Respiratory Device Medical Device
$5.00
Available
GSK Says Lowering Prices in China Caused Higher Sales
$5.00
Available
More Details about Hisun-Pfizer and Merck-Simcere JVs
$5.00
Available
SciClone Gains China Rights to Zensun
$5.00
Available
BioDuro Opens Second China CRO Lab, This One in Shanghai
$5.00
Available
RuiYi and Genor Enter License and Collaboration for Novel mAb
$5.00
Available
Amgen-Zhejiang Beta China JV to Include R&D, Manufacturing
$5.00
Available
WuXi PharmaTech Reports Higher Q1; Analyzes Prospects for its Business
$5.00
Available
RuiYi Selects CMC Biologics to Develop Cell Line for mAb
$5.00
Available
Vectura and KingYork Form China Respiratory JV
$5.00
Available
ScinoPharm and Coland to Develop Oncology Drugs for China
$5.00
Available